United States Government Panel Recommends Wide Spread Use of Pfizer’s COVID-19 Vaccine
Widespread use of Pfizer’s COVID-19 vaccine could begin within days after a U.S. government advisory panel endorsed its widespread use yesterday (Thursday).
In a 17-4 vote with one abstention, the government advisers concluded that the vaccine from Pfizer and its German partner BioNTech appears safe and effective for emergency use in adults and teenagers 16 and older.
All eyes now turn to the FDA staff scientists who will make the final decision on whether to press forward with widespread use of the vaccine.
That decision could come within days to a week according to the FDA’s vaccine director.